Nektar Therapeutics

NKTR · Healthcare · Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the Unit…

Nektar Therapeutics (NKTR), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 0 purchases and 5 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jun 30 and filed Jul 2. The most active filer was Howard W Robin with 4 filings.

Add to watchlist

Filings, ttm

0 buys · 5 sells

Traders, ttm

2 insiders

Volume, ttmiDollar value disclosed in the window

$2.2M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jun 30

Filed Jul 2

ADViAverage daily dollar volume

$69.7M

market data

Share price · 12M

$68.18 (+15.8%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $2.4M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Howard W Robin President & CEO 4 filings JZ

Jonathan Zalevsky Chief R&D Officer 3 filings

Recent filings

Jonathan ZalevskySALE Chief R&D Officer $398K
5,681 sh × $70.00
Exec Jun 30
Filed Jul 2 · 7:06 PM ET Howard W RobinSALE President & CEO $1.2M
20,000 sh across 4 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET Jonathan ZalevskySALE Chief R&D Officer $336K
5,538 sh × $60.71
Exec Jun 15
Filed Jun 17 · 5:30 PM ET Jonathan ZalevskySALE Chief R&D Officer $138K
3,867 sh × $35.67
Exec Jan 20
Filed Jan 22 · 5:30 PM ET Howard W RobinSALE President & CEO $120K
2,207 sh × $54.28
Exec Nov 25 2025
Filed Nov 25 2025 · 5:30 PM ET Howard W RobinSALE President & CEO $102K
2,156 sh × $47.49
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET Howard W RobinSALE President & CEO $125K
3,304 sh × $37.87
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET